BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genes

Human Molecular Genetics
Hisashi HasumiMasahiro Yao

Abstract

Birt-Hogg-Dubé (BHD) syndrome is a hereditary kidney cancer syndrome, which predisposes patients to develop kidney cancer, cutaneous fibrofolliculomas and pulmonary cysts. The responsible gene FLCN is a tumor suppressor for kidney cancer, which plays an important role in energy homeostasis through the regulation of mitochondrial oxidative metabolism. However, the process by which FLCN-deficiency leads to renal tumorigenesis is unclear. In order to clarify molecular pathogenesis of BHD-associated kidney cancer, we conducted whole-exome sequencing analysis using next-generation sequencing technology as well as metabolite analysis using liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry. Whole-exome sequencing analysis of BHD-associated kidney cancer revealed that copy number variations of BHD-associated kidney cancer are considerably different from those already reported in sporadic cases. In somatic variant analysis, very few variants were commonly observed in BHD-associated kidney cancer; however, variants in chromatin remodeling genes were frequently observed in BHD-associated kidney cancer (17/29 tumors, 59%). Metabolite analysis of BHD-associated kidney cancer revealed metabolic reprogramming to...Continue Reading

References

Sep 24, 1999·The Journal of Clinical Investigation·H OndaD J Kwiatkowski
Jun 16, 2005·Journal of the National Cancer Institute·Cathy D VockeW Marston Linehan
Oct 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Masaya BabaBerton Zbar
May 20, 2009·Bioinformatics·Heng Li, Richard Durbin
Oct 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yukiko HasumiW Marston Linehan
Jun 12, 2012·Nature Genetics·Samuel Peña-LlopisJames Brugarolas
Jun 19, 2012·Seminars in Cancer Biology·W Marston Linehan, Christopher J Ricketts
Nov 15, 2012·Journal of the National Cancer Institute·Hisashi HasumiW Marston Linehan
Jun 25, 2013·Nature·UNKNOWN Cancer Genome Atlas Research Network
Jun 26, 2013·Nature Genetics·Yusuke SatoSeishi Ogawa
Apr 26, 2014·The Journal of Clinical Investigation·Ming YanArnim Pause
Apr 26, 2014·PLoS Genetics·Elite PossikArnim Pause
May 14, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James Brugarolas
Jun 9, 2014·Human Molecular Genetics·Yukiko HasumiW Marston Linehan
Aug 27, 2014·Cancer Cell·Caleb F DavisChad J Creighton
Nov 2, 2014·Proceedings of the National Academy of Sciences of the United States of America·Shan-Shan WangJames Brugarolas
Nov 18, 2014·Nature Genetics·Steffen DurinckSomasekar Seshagiri
Nov 30, 2014·Human Molecular Genetics·Magdalena E TyburczyDavid J Kwiatkowski
Dec 6, 2014·Nucleic Acids Research·Yuichi KodamaYasukazu Nakamura
Jan 20, 2015·Pathology International·Yasuhiro IribeMitsuko Furuya
Mar 17, 2015·Proceedings of the National Academy of Sciences of the United States of America·Hisashi HasumiLaura S Schmidt
Nov 5, 2015·The New England Journal of Medicine·W Marston LinehanUNKNOWN Cancer Genome Atlas Research Network
Nov 27, 2015·International Journal of Urology : Official Journal of the Japanese Urological Association·Hisashi HasumiMasahiro Yao
Mar 23, 2017·Cell Reports·Amrita M NargundJames J Hsieh
Dec 26, 2017·Expert Review of Precision Medicine and Drug Development·Mohamad M KronfolJoseph L McClay

❮ Previous
Next ❯

Citations

Mar 3, 2021·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Mauro Antonio DispagnaGennady Bratslavsky
Mar 22, 2020·Annales de pathologie·Virginie VerkarreStéphane Richard
Dec 7, 2019·Biochemical and Biophysical Research Communications·Yasuhiro IsonoHisashi Hasumi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.